News Conference News EuroPCR 2014 EuroPCR 2014: Clinical Challenges, Novel Innovations Share the Limelight Caitlin E. Cox May 28, 2014
News Conference News EuroPCR 2014 Studies Document Initial Steps Toward Percutaneous Mitral Valve Replacement Caitlin E. Cox May 23, 2014
News Conference News EuroPCR 2014 New Iteration of Sapien Device Associated with Low Rates of Early Mortality, Stroke L.A. McKeown May 23, 2014
News Conference News EuroPCR 2014 UK Registry Finds Long-Term Survival After TAVR Depends on Patient Characteristics Caitlin E. Cox May 22, 2014
News Conference News ACC 2014 ACC/i2 2014: Cardiologists Carefully Consider TAVR, Renal Denervation Yael L. Maxwell April 03, 2014
News Conference News ACC 2014 CHOICE Trial, TVT Registry Shed Light on Evolving TAVR Outcomes, Risks L.A. McKeown March 31, 2014
News Conference News ACC 2014 TAV-in-BAV: TAVR Achieves Positive Outcomes In Bicuspid Aortic Valve Disease Jason Kahn March 30, 2014
News Conference News ACC 2014 TAVR With the CoreValve Device Superior to Surgery at 1 Year Yael L. Maxwell March 29, 2014
News Conference News ACC 2014 Depth, Cusp Stretching Linked to Need for Pacemaker after TAVR L.A. McKeown March 29, 2014
News Conference News AHA 2013 AHA 2013: Mix of Positive, Negative Trials Help Guide Interventional Practice November 24, 2013
News Conference News AHA 2013 Registry Study Summarizes Initial US Experience with First Approved TAVR Device Jason Kahn November 16, 2013
News Conference News TCT 2013 TAVR, Surgical AVR Patients Show Similar Rates of Neurological Damage November 03, 2013
News Conference News TCT 2013 Second-Generation TAVR Device Overcomes Issues of Current Valves October 31, 2013
News Conference News TCT 2013 Innovation in Intervention: Perspectives from Industry October 30, 2013
News Conference News TCT 2013 Opportunities Exist to Improve Outcomes in Transapical TAVR October 29, 2013
News Conference News TCT 2013 Data Evolving for Pharmacological Treatment Strategies for Patients with AF and Valvular Heart Disease October 29, 2013
News Conference News TCT 2013 Long-Term Outcomes, Cost May Influence Use of TAVR in Moderate-Risk Patients October 28, 2013